NPPA allows price hike for coronary stents to reflect inflation, impacting heart patients' treatment costs in India.

Coronary artery bypass grafting is a more invasive procedure where surgeons use blood vessels from another part of the body ...

NPPA directed all manufacturers and importers of coronary stents whose retail prices are lower than the ceiling set by it to ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

NPPA allows stent manufacturers to revise prices by 1.74% based on WPI, ensuring compliance with DPCO regulations.

The Stanislaus Medical Society is recognizing the career of a leading cardiologist in Modesto. Dr. Satnam Ludder is receiving ...

The life-saving devices will see prices rise by nearly Rs 700 in some cases as the MRP is adjusted for inflation.

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Abbott received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy (IVL) system.

Abbott (ABT) announced that the U.S. Food and Drug Administration, FDA, has approved an investigational device exemption, IDE, for its Coronary ...

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...